Total Payments
$8,146
2024 Payments
$346.89
Companies
13
Transactions
50
Medicare Patients
916
Medicare Billing
$162,994
Payment Breakdown by Category
Consulting$2,610 (32.0%)
Travel$2,454 (30.1%)
Education$1,617 (19.8%)
Food & Beverage$1,465 (18.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,610 | 1 | 32.0% |
| Travel and Lodging | $2,454 | 9 | 30.1% |
| Education | $1,617 | 4 | 19.8% |
| Food and Beverage | $1,465 | 36 | 18.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $4,406 | 17 | $0 (2019) |
| ImmunoGen, Inc. | $2,789 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $439.92 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $101.12 | 4 | $0 (2024) |
| Eisai Inc. | $98.12 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $81.75 | 5 | $0 (2024) |
| CONMED Corporation | $76.92 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $51.07 | 3 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $25.45 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $23.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $346.89 | 17 | Novartis Pharmaceuticals Corporation ($70.36) |
| 2023 | $2,897 | 9 | ImmunoGen, Inc. ($2,789) |
| 2022 | $127.74 | 3 | AstraZeneca Pharmaceuticals LP ($95.00) |
| 2021 | $291.33 | 3 | AstraZeneca Pharmaceuticals LP ($252.01) |
| 2019 | $1,296 | 8 | Intuitive Surgical, Inc. ($1,296) |
| 2018 | $3,187 | 10 | Intuitive Surgical, Inc. ($3,110) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | PFIZER INC. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Oncology | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: ONCOLOGY | ||||||
| 07/31/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: ONCOLOGY | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Oncology | ||||||
| 05/28/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Oncology | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 04/30/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Oncology | ||||||
| 02/15/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Oncology | ||||||
| 02/15/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Oncology | ||||||
| 02/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Oncology | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $30.76 | General |
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Oncology | ||||||
| 10/11/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LENVIMA | Education | In-kind items and services | $10.85 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2023 | ImmunoGen, Inc. | Elahere (Biological) | Consulting Fee | Cash or cash equivalent | $2,610.00 | General |
| Category: Oncology | ||||||
| 06/01/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $116.31 | General |
| Category: Oncology | ||||||
| 06/01/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $50.96 | General |
| Category: Oncology | ||||||
| 05/17/2023 | ImmunoGen, Inc. | Elahere (Biological) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 168 | 289 | $147,344 | $25,965 |
| 2022 | 5 | 201 | 335 | $156,799 | $28,722 |
| 2021 | 5 | 214 | 277 | $191,149 | $43,143 |
| 2020 | 10 | 333 | 392 | $259,791 | $65,164 |
Total Patients
916
Total Services
1,293
Medicare Billing
$162,994
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 99 | 194 | $84,002 | $14,645 | 17.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 48 | 74 | $44,271 | $8,333 | 18.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 21 | 21 | $19,071 | $2,988 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 90 | 204 | $85,476 | $15,468 | 18.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 44 | 58 | $34,278 | $6,929 | 20.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 20 | 20 | $18,020 | $3,137 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 36 | 42 | $11,424 | $1,936 | 17.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $7,601 | $1,252 | 16.5% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 21 | 21 | $109,437 | $13,520 | 12.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 106 | $20,564 | $11,498 | 55.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 38 | 38 | $14,592 | $6,481 | 44.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 43 | 55 | $23,045 | $4,694 | 20.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 24 | $6,432 | $2,923 | 45.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 21 | 22 | $12,679 | $2,740 | 21.6% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 11 | 11 | $4,400 | $1,287 | 29.2% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 30 | 30 | $145,256 | $21,461 | 14.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 69 | 69 | $26,496 | $12,022 | 45.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 67 | 89 | $23,852 | $10,171 | 42.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 79 | $15,326 | $7,204 | 47.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 22 | $8,184 | $3,599 | 44.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 33 | 38 | $9,500 | $3,545 | 37.3% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2020 | 12 | 12 | $19,980 | $2,705 | 13.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 26 | $3,770 | $1,610 | 42.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 16 | $3,280 | $1,430 | 43.6% |
| 38900 | Lymph node imaging during surgery | Facility | 2020 | 11 | 11 | $4,147 | $1,416 | 34.1% |
About Dr. Barbara Buttin, M.D
Dr. Barbara Buttin, M.D is a Gynecologic Oncology healthcare provider based in Zion, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700876307.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Buttin, M.D has received a total of $8,146 in payments from pharmaceutical and medical device companies, with $346.89 received in 2024. These payments were reported across 50 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($2,610).
As a Medicare-enrolled provider, Buttin has provided services to 916 Medicare beneficiaries, totaling 1,293 services with total Medicare billing of $162,994. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Zion, IL
- Active Since 10/25/2005
- Last Updated 10/13/2021
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1700876307
Products in Payments
- Da Vinci Surgical System (Device) $4,406
- Elahere (Biological) $2,789
- LYNPARZA (Drug) $439.92
- Lenvima (Drug) $98.12
- AirSeal (Device) $76.92
- JEMPERLI (Biological) $51.07
- KEYTRUDA (Biological) $49.78
- MEKINIST (Drug) $41.45
- LYNPARZA (Biological) $31.97
- KISQALI (Drug) $28.91
- MYRISK (Device) $25.45
- Enhertu (Drug) $23.41
- LUMAKRAS (Drug) $21.89
- ELAHERE (Drug) $17.63
- TIVDAK (Biological) $13.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.